News for adrenal insufficiency;Les actualités de l'insuffisance surrénalienne

Annales d'Endocrinologie

Volumn 69, Issue SUPPL. 1, 2008, Pages

  Nunes, M L ^a   Tabarin, A ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Adrenal insufficiency; Delayed release hydrocortisone; Glucocorticoid replacement therapy; Life expectancy

Indexed keywords

CHRONOCORT; CORTICOSTEROID; DUOCORT; GLUCOCORTICOID; HYDROCORTISONE; OPIATE; UNCLASSIFIED DRUG;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; ARTICLE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; MORTALITY; QUALITY OF LIFE; TABLET FORMULATION;

ADRENAL INSUFFICIENCY; BODY MASS INDEX; HUMANS; HYDROCORTISONE; LIFE EXPECTANCY; PROGNOSIS;

EID: 54349121010     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(08)73968-4     Document Type: Article

References (46)

1. Cetinkaya S., Ozon A., and Yordam N. Diagnostic value of salivary cortisol in children with abnormal adrenal cortex functions. Horm Res 67 (2007) 301-306
2. Marcus-Perlman Y., Tordjman K., Greenman Y., Limor R., Shenkerman G., Osher E., et al. Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test. Clin Endocrinol (Oxf) 64 (2006) 215-218
3. Patel R.S., Wallace A.M., Hinnie J., and McGarry G.W. Preliminary results of a pilot study investigating the potential of salivary cortisol measurements to detect occult adrenal suppression secondary to steroid nose drops. Clin Otolaryngol Allied Sci 26 (2001) 231-234
4. Viardot A., Huber P., Puder J.J., Zulewski H., Keller U., and Muller B. Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J Clin Endocrinol Metab 90 (2005) 5730-5736
5. Rittmaster R.S., Loriaux D.L., and Cutler Jr. G.B. Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women. J Clin Endocrinol Metab 61 (1985) 462-466
6. Nasrallah M.P., and Arafah B.M. The value of dehydroepiandrosterone sulfate measurements in the assessment of adrenal function. J Clin Endocrinol Metab 88 (2003) 5293-5298
7. Parker L.N. Control of adrenal androgen secretion. Endocrinol Metab Clin North Am 20 (1991) 401-421
8. Hall G.M., Lacoumenta S., Hart G.R., and Burrin J.M. Site of action of fentanyl in inhibiting the pituitary-adrenal response to surgery in man. Br J Anaesth 65 (1990) 251-253
9. Oltmanns K.M., Fehm H.L., and Peters A. Chronic fentanyl application induces adrenocortical insufficiency. J Intern Med 257 (2005) 478-480
10. Raff H., Norton A.J., Flemma R.J., and Findling J.W. Inhibition of the adrenocorticotropin response to surgery in humans: interaction between dexamethasone and fentanyl. J Clin Endocrinol Metab 65 (1987) 295-298
11. Broadbear J.H., Winger G., and Woods J.H. Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology (Berl) 176 (2004) 398-406
12. Howlett T.A., and Rees L.H. Endogenous opioidpeptides and hypothalamo-pituitary function. Annu Rev Physiol 48 (1986) 527-536
13. Buckingham J.C. Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides. Neuroendocrinology 35 (1982) 111-116
14. Meites J., Bruni J.F., Van Vugt D.A., and Smith A.F. Relation of endogenous opioid peptides and morphine to neuroendocrine functions. Life Sci 24 (1979) 1325-1336
15. Delitala G., Grossman A., and Besser M. Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion. Neuroendocrinology 37 (1983) 275-279
16. Nock B., Cicero T.J., and Wich M. Chronic exposure to morphine decreases physiologically active corticosterone in both male and female rats but by different mechanisms. J Pharmacol Exp Ther 286 (1998) 875-882
17. Chang A.Y., Ghayee H.K., and Auchus R.J. Dehydroepiandrosterone replacement therapy-panacea, snake oil, or a bit of both?. Nat Clin Pract Endocrinol Metab 4 (2008) 442-443
18. Molimard M., Girodet P.O., Pollet C., Fourrier-Reglat A., Daveluy A., Haramburu F., et al. Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation. Drug Saf 31 (2008) 769-774
19. Kennedy M.J., Carpenter J.M., Lozano R.A., and Castile R.G. Impaired recovery of hypothalamic-pituitary-adrenal axis function and hypoglycemic seizures after high-dose inhaled corticosteroid therapy in a toddler. Ann Allergy Asthma Immunol 88 (2002) 523-526
20. Lipworth B.J. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med 159 (1999) 941-955
21. Lipworth B.J., and The ISOLDE trial. Side effects with inhaled steroids should not be forgotten. BMJ 321 (2000) 1349
22. Patel L., Wales J.K., Kibirige M.S., Massarano A.A., Couriel J.M., and Clayton P.E. Symptomatic adrenal insufflciency during inhaled corticosteroid treatment. Arch Dis Child 85 (2001) 330-334
23. Russell G. Inhaled corticosteroids and adrenal insufflciency. Arch Dis Child 87 (2002) 455-456
24. Todd G.R., Acerini C.L., Buck J.J., Murphy N.P., Ross-Russell R., Warner J.T., et al. Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate. Eur Respir J 19 (2002) 1207-1209
25. White A., and Woodmansee D.P. Adrenal insufflciency from inhaled corticosteroids. Ann Intern Med 140 (2004) W27
26. Mortimer K.J., Tata L.J., Smith C.J., West J., Harrison T.W., Tattersfleld A.E., et al. Oral and inhaled corticosteroids and adrenal insufflciency: a case-control study. Thorax 61 (2006) 405-408
27. Oelkers W. Adrenal insufflciency. N Engl J Med 335 (1996) 1206-1212
28. Dunlop D. Eighty-six cases of Addison's disease. Br Med J 2 (1963) 887-891
29. Mason A.S., Meade T.W., Lee J.A., and Morris J.N. Epidemiological and clinical picture of Addison's disease. Lancet 2 (1968) 744-747
30. Bergthorsdottir R., Leonsson-Zachrisson M., Oden A., and Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 91 (2006) 4849-4853
31. Filipsson H., Monson J.P., Koltowska-Haggstrom M., Mattsson A., and Johannsson G. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 91 (2006) 3954-3961
32. Hahner S., Loeffler M., Fassnacht M., Weismann D., Koschker A.C., Quinkler M., et al. Impaired subjective health status in 256 patients with adrenal insufflciency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab 92 (2007) 3912-3922
33. Lovas K., Loge J.H., and Husebye E.S. Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 56 (2002) 581-588
34. Arlt W., Rosenthal C., Hahner S., and Allolio B. Quality of gluco-corticoid replacement in adrenal insufflciency: clinical assessment vs. timed serum cortisol measurements. Clin Endocrinol (Oxf) 64 (2006) 384-389
35. Raffln-Sanson M.L., and Bertagna X. Régulation de la fonction corticotrope. Traité d'endocrinologie. Ref Type: Serial (Book, Mono-graph). Médecine-Sciences Flammarion Eds (2008) 295-301
36. Jacobson L. Hypothalamic-pituitary-adrenocortical axis regulation. Endocrinol Metab Clin North Am 34 (2005) 271-292 vii
37. Esteban N.V., Loughlin T., Yergey A.L., Zawadzki J.K., Booth J.D., Winterer J.C., et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 72 (1991) 39-45
38. Groves R.W., Toms G.C., Houghton B.J., and Monson J.P. Corticosteroid replacement therapy: twice or thrice daily?. J R Soc Med 81 (1988) 514-516
39. Peacey S.R., Guo C.Y., Robinson A.M., Price A., Giles M.A., Eastell R., et al. Glucocorticoid replacement therapy: are patients over treated and does it matter?. Clin Endocrinol (Oxf) 46 (1997) 255-261
40. Howlett T.A. An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol (Oxf) 46 (1997) 263-268
41. Mah P.M., Jenkins R.C., Rostami-Hodjegan A., Newell-Price J., Doane A., Ibbotson V., et al. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 61 (2004) 367-375
42. Nieman L. Treament of adrenal insufficiency in adults. Ref Type: Internet Communication 2008.
43. Merza Z., Rostami-Hodjegan A., Memmott A., Doane A., Ibbotson V., Newell-Price J., et al. Circadian hydrocortisone infusions in patients with adrenal insufflciency and congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 65 (2006) 45-50
44. Lovas K., and Husebye E.S. Continuous subcutaneous hydrocortisone infusion in Addison's disease. Eur J Endocrinol 157 (2007) 109-112
45. Newell-Price J., Whiteman M., Rostami-Hodjegan A., Darzy K., Shalet S., Tucker G.T., et al. Modifled-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers. Clin Endocrinol (Oxf) 68 (2008) 130-135
46. Johannsson G, Batcheller G. Improvements in cortisol replacement therapy. Ref Type: Internet Communication www.CSRF.net 2008.